Founded at the Abramson Cancer Center at the University of Pennsylvania

Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid Cancers

Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid Cancers

Ravi B. Parikh, MD, MPP; Eun Jeong Min, PhD; E. Paul Wileyto, PhD; Fauzia Riaz, MD; Cary P. Gross, MD; Roger B. Cohen, MD; Rebecca A. Hubbard, PhD; Qi Long, PhD; Ronac Mamtani, MD, MSCE

JAMA Oncology | 2021